Kesimpta 欧州連合 - アイスランド語 - EMA (European Medicines Agency)

kesimpta

novartis ireland ltd - ofatumumab - heila-og mænusigg, köstum tilkynnt - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.

Ozawade 欧州連合 - アイスランド語 - EMA (European Medicines Agency)

ozawade

bioprojet pharma - pitolisant - sleep apnea, obstructive - Önnur lyf í taugakerfinu - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).

Methylphenidate STADA Hart hylki með breyttan losunarhraða 30 mg アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate stada hart hylki með breyttan losunarhraða 30 mg

stada arzneimittel ag - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 30 mg

Methylphenidate STADA Hart hylki með breyttan losunarhraða 20 mg アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate stada hart hylki með breyttan losunarhraða 20 mg

stada arzneimittel ag - methylphenidatum hýdróklóríð; methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 20 mg

Medikinet CR (Medikinet retard) Hart hylki með breyttan losunarhraða 30 mg アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

medikinet cr (medikinet retard) hart hylki með breyttan losunarhraða 30 mg

medice arzneimittel pütter gmbh & co. kg* - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 30 mg